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This study investigated whether increased glucagon levels, caused by the short-term 
administration of glucagon, lead to an increase in gene expression of the insulin 
receptor (InsR) in calf hepatocytes cultured in vitro. After 72 hrs of culturing, 
glucagon was added to calf hepatocytes at a five different concentrations of 0, 1, 10, 
100 and 1000 nM. InsR mRNA expression was determined by internally controlled 
reverse transcriptase polymerase chain reaction. No changes in InsR mRNA 
expression (InsR/β-actin gray scale) were detected in hepatocytes treated with 
glucagon compared with the control group and there were no significant differences 
between the different concentrations. In conclusion, short-term administration of 
glucagon did not directly influence the gene expression of InsR in primary cultured 
calf hepatocytes. 
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INTRODUCTION 
 
 Dairy cows experience an increased demand for glucose 
to support milk production during early lactation. Increased 
glucose demand can be met through increased 
gluconeogenesis, an increased supply of glucose precursors, 
or a combination of both of these processes (Williams et al., 
2006). Hormonal regulation of nutrient partitioning is of 
critical importance in maintaining the metabolic equilibrium 
of lactating dairy cows. The production of glucose by the 
liver and the utilization of glucose by extrahepatic tissues are 
vital steps in the conversion of feed nutrients to milk. The 
roles of glucagon and insulin in the regulation of energy 
metabolism in ruminants are crucial. Insulin is an anabolic 
hormone that decreases the output of glucose by the liver and 
has been related inversely to milk yield. It binds to a 
glycoprotein receptor (InsR) in the cell membrane that is a 
member of the tyrosine kinase receptor family. Binding of 
insulin to InsR is crucial in maintaining blood glucose 
homeostasis by promoting glycogen synthesis (Liu et al., 
2010). 
Glucagon is a peptide comprising of 29 amino acids 
that is  released from pancreatic  α-cells and  acts against 
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insulin. Glucagon promotes gluconeogenesis and 
stimulates glycogenolysis leading to glucose output from 
hepatocytes when blood glucose levels are low (Longuet 
et al., 2008). These actions are transduced via a G protein-
coupled receptor. In recent years, glucagon has gained 
much interest in the field of ruminant research, in 
particular with regard to its role in energy metabolism and 
as a feed supplement (Bobe et al., 2009).  In the liver, 
glucagon binds to its receptor and activates signal 
transduction networks and transcription factors, playing 
an important physiological role (Berglund et al., 2010). 
At the onset of lactation, the levels of plasma insulin 
and hepatic glycogen decrease with a simultaneous 
increase in the levels of plasma glucagon and hepatic 
triacylglycerols. In addition, the glucagon concentration 
has been reported to increase under various conditions 
such as dexamethasone treatment increases the glucagon 
concentration in the plasma of young calves (Hammon et 
al., 2005). Similarly, the glucagon concentration also 
increases with weaning in dairy calves (Klotz and 
Heitmann, 2006). Further, both glucagon concentration 
and the glucagon-to-insulin ratio have been reported to be 
augmented by rumen-protected fat feeding (Hammon et 
al., 2008). The plasma glucagon concentration in 
postpartum dairy cows quadrupled after the administration 
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of increasing amounts of chromium-L-methionine (Smith 
et al., 2008). In hot environments, glucagon responses 
following arginine and butyrate injections were 
augmented significantly in heifers (Itoh et al., 1998). 
Daily subcutaneous injections of 15 mg of glucagon 
during the first 14 days postpartum with or without co-
administration of 400 ml of pure glycerol orally was 
reported to alleviate some of the symptoms of fatty liver, 
such as the increase in plasma non-esterified fatty acids 
and decrease in plasma glucose and insulin levels, in 
Holstein dairy cows after parturition (Osman et al., 2010). 
Hepatocytes in primary monolayer culture are a well-
established experimental model. In this study, the in vitro 
effect of glucagon on InsR mRNA expression in cultured 
calf hepatocytes was investigated.  
 
MATERIALS AND METHODS 
 
A liver (caudate process) was obtained from a 
thiamylal sodium-anesthetized neonatal Holstein calf 
(male) under sterile conditions. Hepatocytes were cultured 
using the collagenase perfusion method as decribed 
previously (Zhang et al., 2011). Glucagon was added at 
five different concentrations of 0, 1, 10, 100, and 1000 
nM to pre-cultured hepatocytes in five different groups). 
Each concentration group comprised six repeats. 
Primer design and DNA amplification  were 
performed as described previously (Liu et al., 2010). After 
incubation for 12 hrs, total RNA was isolated from 
hepatocytes by using the TRIzol RNA purification kit 
(Invitrogen, Carlsbad, California, USA) according to the 
supplier’s protocol. The RNA extract was diluted (1:40) 
and analyzed at 260 and 280 nm by spectrophotometry. 
Samples with an optical density ratio at 260/280 of >1.9 
were retained for further analysis (Zhang et al., 2011). 
Complementary DNA synthesis and InsR mRNA 
internally controlled reverse transcriptase polymerase 
chain reaction (RT-PCR) were performed according to 
Liu  et al. (2010). Image processing and grey-scale 
analysis was performed with the TANLON gel image 
analysis system (Shanghai, China). Based on the grey-
scale analysis, the ratio of the grey-level between the PCR 
products of InsR and the β-actin genes indicated the 
relative changes in expression of the InsR gene in the test 
samples. 
Data analysis was performed using SPSS version 18.0 
(SPSS Inc., Chicago, IL, USA). Statistical significance 
was determined by one-way ANOVA, followed by 
Duncan’s least significant difference test. P<0.05 was 
considered to be significant.  
 
RESULTS AND DISCUSSION 
 
As shown in Fig.1 and Table 1, with continuously 
increasing glucagon concentrations, there were no 
significant differences in the InsR mRNA expression 
levels of hepatocytes (InsR/β-actin gray scale) between 
the different concentrations compared with the control 
group (P>0.05). 
Dairy cows in early lactation exhibit a negative 
energy balance as the glucose supply is insufficient. One 
of the physiological functions of glucagon is to counter 
hypoglycemia. It is stimulated during hypoglycemia and 
promotes hepatic glucose production, ultimately raising 
blood glucose levels.  
 
 
 
Fig. 1: PCR products of the insR gene in hepatocytes treated with 
different concentrations of glucagons. M: Marker DL 2000; lanes 1–5: 
Glucagons concentrations of 0, 1, 10, 100, and 1000 nM, respectively. 
 
Table 1: Abundance of InsR mRNA in primary hepatocytes treated 
with different concentrations of glucagons (n=6) 
 Glucagon (nM)    InsR mRNA (µg; mean±SD) 
0 0.58±0.06 
1 0.54±0.09 
10 0.53±0.10 
100 0.52±0.04 
1000 0.55±0.03 
All values are statistically similar (P>0.05). 
 
Glucagon infusion had a prominent hyperglycemic–
glycogenolytic stimulatory effect in calves, accompanied 
by a marked increase in plasma insulin (Madsen et al., 
1976). Administration of glucagon over 24 hours did not 
alter cytosolic phosphoenolpyruvate carboxykinase 
mRNA expression or result in immediate alterations in 
total phosphoenolpyruvate carboxykinase activity or 
gluconeogenic capacity in the liver of dairy cows 
(Williams et al., 2006). Fatty liver is a metabolic disease 
that affects up to 50% of dairy cows in early lactation. 
Fatty liver and ketosis can be treated by consecutive 
intravenous injections of glucagons (10 mg/day) for 14 
days (Bobe et al., 2003).  
InsR and glucagons have been shown to interact. The 
appropriate expression of InsR in mouse pancreatic α-
cells is required for glucose-dependent glucagon secretion 
(Diao  et al., 2005). Incubation of rat liver cells with 
glucagon led to an increase in the phosphorylation of 
specific serine residues within insulin receptors, 
particularly in the presence of insulin (Issad et al., 1992).                  
The results of this study suggested that short-term 
administration of glucagon did not directly influence the 
gene expression of InsR in primary cultured calf 
hepatocytes. This indirectly suggested that the short-term 
administration of glucagon to regulate glucose levels in 
dairy cows with fatty liver disease or dairy cows during 
early lactation might not be related to InsR gene 
expression. Determining InsR gene expression in the liver 
of cows which have been injected glucagons can be 
favorable to support the results. Further studies using 
extended incubation times (e.g., 72, 144, or 196 hrs) may 
be helpful in elucidating the effect of long-term 
administration of glucagon on the gene expression of InsR 
in cultured calf hepatocytes.  
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